IDXX vs. MCK: IDEXX Laboratories vs. McKesson Stock Comparison

Company Profile

IDEXX Laboratories (IDXX) and McKesson (MCK) both fall under the Health Care Equipment & Services industry group, but IDXX is classified in Health Care Equipment & Supplies while MCK is classified in Health Care Providers & Services.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

IDEXX Laboratories (IDXX) has an aggressive beta of 1.44, indicating higher sensitivity to broad-market moves, while McKesson (MCK) is defensive at 0.26 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Capital efficiency shows on one side only: IDEXX Laboratories (IDXX) earns 68.93% on shareholders’ equity, ranked against its industry; McKesson (MCK) has no ROE this period.

IDEXX Laboratories (IDXX) at 25.36% retains a top-quartile share of revenue as profit, ahead of McKesson (MCK) at 1.12%, which keeps about the industry-typical share.

IDEXX Laboratories (IDXX) at 33.14% operates in the top operating margin quartile, ahead of McKesson (MCK) at 1.48%, which runs around its industry’s norm.

Profitability Metrics

Growth

Both IDEXX Laboratories (IDXX) at 10.42% and McKesson (MCK) at 12.36% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

McKesson (MCK) at 49.22% sits in the top EPS growth quartile, while IDEXX Laboratories (IDXX) at 22.59% is closer to the peer norm — faster per-share earnings growth for MCK.

Growth Metrics

Financial Strength

Both IDEXX Laboratories (IDXX) at 1.19 and McKesson (MCK) at 0.90 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.

Only one side’s leverage can be read here: IDEXX Laboratories (IDXX) carries debt-to-equity ratio of 0.52 against its industry range, while McKesson (MCK) reports no figure this period.

Financial Strength Metrics

Dividends

IDEXX Laboratories (IDXX) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile McKesson (MCK) reports a yield of 0.32%, ranking against industry peers normally.

IDEXX Laboratories (IDXX) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile McKesson (MCK) reports a payout of 8.77%, ranking against industry peers normally.

Dividend Metrics

Valuation

Both IDEXX Laboratories (IDXX) at 45.56 and McKesson (MCK) at 27.36 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.

McKesson (MCK) at 0.29 sits in the cheaper P/S ratio quartile while IDEXX Laboratories (IDXX) at 11.42 prices above its industry range — a wide gap in sales valuation between them.

McKesson (MCK) reports a negative P/B ratio of -30.85, meaning negative book equity — the multiple itself is not meaningful for valuation. Meanwhile IDEXX Laboratories (IDXX) reports 28.50, ranking against industry peers normally.

Valuation Metrics